Luc Dirix Selected Research

Luc Dirix Research Topics

Disease

47	Neoplasms (Cancer) 02/2024 - 06/2002
40	Breast Neoplasms (Breast Cancer) 02/2024 - 11/2005
11	Neoplasm Metastasis (Metastasis) 12/2023 - 05/2008
11	Prostatic Neoplasms (Prostate Cancer) 03/2021 - 01/2017
9	Disease Progression 01/2022 - 08/2012
7	Inflammatory Breast Neoplasms 02/2024 - 05/2015
7	Basal Cell Carcinoma (Rodent Ulcer) 07/2016 - 06/2012
6	Circulating Neoplastic Cells 07/2022 - 11/2005
4	Carcinoma (Carcinomatosis) 01/2023 - 01/2018
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2016
3	Fatigue 01/2022 - 07/2010
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2014
2	Lymphatic Metastasis 12/2023 - 01/2021
2	Triple Negative Breast Neoplasms 01/2019 - 01/2014
2	Asthenia 01/2018 - 01/2017
2	Anemia 10/2014 - 07/2010
1	Inflammation (Inflammations) 02/2024
1	Epistaxis (Nosebleed) 01/2022
1	Proteinuria 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Renal Insufficiency (Renal Failure) 10/2020

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 02/2024 - 11/2005
10	Estrogen ReceptorsIBA 07/2022 - 05/2008
8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2008
8	Biomarkers (Surrogate Marker)IBA 03/2021 - 06/2015
7	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2017
5	human ERBB2 proteinIBA 01/2022 - 11/2005
5	HhAntag691IBA 06/2015 - 06/2012
5	Trastuzumab (Herceptin)FDA Link 04/2015 - 03/2007
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 07/2010
4	avelumabIBA 01/2023 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2022 - 11/2013
4	Bevacizumab (Avastin)FDA Link 01/2022 - 11/2016
4	PlatinumIBA 10/2020 - 10/2014
3	AntigensIBA 01/2023 - 04/2014
3	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 03/2013
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 06/2002
3	B7-H1 AntigenIBA 01/2020 - 01/2018
3	Monoclonal AntibodiesIBA 01/2020 - 04/2014
3	Abiraterone AcetateIBA 01/2018 - 01/2017
3	NVP-BKM120IBA 01/2017 - 04/2014
3	Aromatase InhibitorsIBA 10/2016 - 05/2013
3	Tamoxifen FDA LinkGeneric 06/2015 - 04/2011
3	Ado-Trastuzumab EmtansineIBA 05/2015 - 03/2013
3	Docetaxel (Taxotere)FDA Link 03/2013 - 07/2010
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Everolimus FDA Link 12/2020 - 01/2008
2	exemestane (Aromasin)FDA Link 12/2020 - 04/2011
2	Transcription Factors (Transcription Factor)IBA 04/2020 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2018
2	abirateroneIBA 07/2019 - 01/2018
2	enzalutamideIBA 07/2019 - 01/2018
2	olaparibIBA 11/2018 - 10/2016
2	TrabectedinIBA 01/2018 - 10/2014
2	dactolisibIBA 01/2017 - 01/2017
2	Letrozole (Femara)FDA LinkGeneric 10/2016 - 01/2008
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2016 - 10/2014
2	Rifampin (Rifampicin)FDA LinkGeneric 10/2016 - 10/2014
2	Cytochrome P-450 CYP3AIBA 10/2016 - 10/2014
2	EnzymesIBA 10/2016 - 10/2014
2	Phenobarbital (Luminal)FDA Link 10/2016 - 11/2005
2	sonidegibIBA 07/2016 - 06/2015
2	Cytotoxins (Cytolysins)IBA 04/2015 - 03/2013
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2012 - 04/2011
1	X-Linked Inhibitor of Apoptosis ProteinIBA 02/2024
1	Type I Tumor Necrosis Factor ReceptorsIBA 02/2024
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2024
1	birinapantIBA 02/2024
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 02/2024
1	taxaneIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Aurora Kinase AIBA 06/2023
1	Interleukin-12 (IL 12)IBA 01/2023
1	Capsules (Microcapsules)IBA 01/2023
1	Complement System Proteins (Complement)IBA 07/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	N 30IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 05/2021
1	Collagen Type IV (Type IV Collagen)IBA 01/2021
1	CollagenIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	ribociclibIBA 12/2020
1	AntibodiesIBA 10/2020
1	LigandsIBA 10/2020
1	AlbuminsIBA 10/2020
1	apalutamideIBA 06/2020

Therapy/Procedure

34	Therapeutics 02/2024 - 11/2005
13	Drug Therapy (Chemotherapy) 01/2023 - 12/2007
9	Castration 03/2021 - 01/2017
4	Radiotherapy 12/2023 - 01/2021
2	Intravenous Infusions 01/2020 - 01/2018
2	Adjuvant Chemotherapy 11/2018 - 12/2012
2	Aftercare (After-Treatment) 10/2016 - 12/2012
1	Neoadjuvant Therapy 12/2023
1	Immunotherapy 01/2023
1	Activities of Daily Living (ADL) 01/2022